CATX - Perspective Therapeutics Inc.
Perspective Therapeutics Inc. Logo

CATX - Perspective Therapeutics Inc.

https://www.perspectivetherapeutics.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage

No recent news found.

AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

None

52W High
$16.31
52W Low
$1.60

MA Status:
50D: Below 200D: Above
Beta (~1 neutral, <0.9 lower risk)
1.21
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-21.91
EV/Revenue (<3 favorable)
68.73
P/S (TTM) (<3 favorable)
208.06
P/B (<3 favorable)
0.97
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
18.82%
Institutions (25–75% balanced)
58.72%
Shares Outstanding
74,263,000
Float
58,977,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
1,235,000
Gross Profit (TTM)
-51,086,000
EPS (TTM)
-1.37
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-82.89%
ROE (TTM) (>15% strong)
-0.32%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-0.45
Momentum
Bearish momentum
Value
-0.1048
Previous
-0.1218
Trend
Rising
Signal Cross
No cross

As of
Sep. 12, 2025